Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer

E-ISSN： 1873-5576|13|3|245-251

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.3, 2013-03, pp. : 245-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation

Current Pharmaceutical Design, Vol. 23, Iss. 11, 2017-05 ,pp. : 1633-1638

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3070-3080

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 275-286

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy

Clinical Cancer Drugs, Vol. 3, Iss. 1, 2016-05 ,pp. : 36-62

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K/AKT/mTOR-Signal Transduction Pathway as Drug Target in Triple-Negative Breast Cancer

Clinical Cancer Drugs, Vol. 4, Iss. 1, 2017-05 ,pp. : 47-58

Bentham Science Publishers

Access to resources Recommend Favorite